Andere Kunden interessierten sich auch für
![Seroprevalence and Molecular Detection of Hepatitis Delta Virus (HDV)]( "Seroprevalence and Molecular Detection of Hepatitis Delta Virus (HDV)")
Seroprevalence and Molecular Detection of Hepatitis Delta Virus (HDV)26,99 €![Seroprevalence of hepatitis B and C viruses]( "Seroprevalence of hepatitis B and C viruses")
Seroprevalence of hepatitis B and C viruses35,99 €![Cytomegalovirus Seroprevalence among Pregnant women in Jahun, Nigeria]( "Cytomegalovirus Seroprevalence among Pregnant women in Jahun, Nigeria")
Cytomegalovirus Seroprevalence among Pregnant women in Jahun, Nigeria26,99 €![Seroprevalence of toxoplasmosis in relation to knowledge and practice]( "Seroprevalence of toxoplasmosis in relation to knowledge and practice")
Seroprevalence of toxoplasmosis in relation to knowledge and practice31,99 €![Chickenpox seroprevalence among children in Kaduna State, Nigeria]( "Chickenpox seroprevalence among children in Kaduna State, Nigeria")
Chickenpox seroprevalence among children in Kaduna State, Nigeria35,99 €![Seroprevalance of Human parvovirus B19 among blood donor volunteers]( "Seroprevalance of Human parvovirus B19 among blood donor volunteers")
Seroprevalance of Human parvovirus B19 among blood donor volunteers33,99 €![The Incidence of Kala-azar among Blood Donors in Gadarif State]( "The Incidence of Kala-azar among Blood Donors in Gadarif State")
The Incidence of Kala-azar among Blood Donors in Gadarif State28,99 €
Hepatitis E virus (HEV) is significant international public health problem and is estimated that 2.3 billion people are infected globally. Blood-borne transmission of HEV had been investigated as indirect evidence implicating HEV as a potential transfusion risk by many investigators worldwide. The high prevalence rate of anti-HEV among blood donors, this will raise the potential risk of HEV infection by blood transfusion so that screening of HEV among blood donors before transfusion is very important.